18.07.2025 • Topics

ISPE Good Practice Guide: Validation 4.0

The Validation 4.0 Guide provides a comprehensive approach to ensuring product quality and patient safety throughout a pharmaceutical product's lifecycle. A Holistic Control Strategy (HCS) in this context means moving beyond traditional, static, upfront and localized validation controls to a dynamic, data-driven, and continuous approach to managing risks and quality along the broader value chain.

Guide cover
© ISPE

This Guide is intended to be an early introduction into modern validation thinking in an increasingly digital world that offers new capabilities for managing and controlling manufacturing processes. The structure starts with an overview of methodology considerations, covers foundational enablers, required capabilities and a section on real-life case studies that have been selected to explain aspects to consider when adopting Validation 4.0 in practice.

A Maturity Self-Assessment Tool is included in the E-Reader (under Materials/Supplements) as a downloadable Microsoft Excel file to purchasers of the Guide. See the FAQ for accessing instructions.

The primary intention behind this self-assessment tool is to empower organizations to accurately characterize their current state of maturity and, more importantly, identify specific areas where targeted improvements can be made.

ISPE Good Practice Guide: Validation 4.0

Click here to purchase the guide.

Access Here!

Company

Logo:

International Society for Pharmaceutical Engineering (ISPE)

6110 Executive Blvd.
20852 North Bethesda
US

Company contact







Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read